Renal function and dysfunction

Current Opinion in Anaesthesiology

Volumn 14, Issue 6, 2001, Pages 699-706

  Byers, Jason ^a   Sladen, Robert N ^a  

^a Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENT; ANTIHYPERTENSIVE AGENT; APROTININ; CALCIUM CHANNEL BLOCKING AGENT; CELECOXIB; CONTRAST MEDIUM; CYCLOOXYGENASE 2 INHIBITOR; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOPAMINE; FUROSEMIDE; INHALATION ANESTHETIC AGENT; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN INHIBITOR; TRANEXAMIC ACID;

AGED; AORTA SURGERY; CARDIOPULMONARY BYPASS; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; EVALUATION; GENETIC POLYMORPHISM; HEART FAILURE; HEART SURGERY; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; NEPHROTOXICITY; OBSTRUCTIVE JAUNDICE; PRIORITY JOURNAL; PROGNOSIS; PUBLICATION; REVASCULARIZATION; REVIEW; RISK ASSESSMENT;

EID: 0035203872     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001503-200112000-00017     Document Type: Review

References (43)

1. The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction
2. Prediction of creatinine clearance from serum creatinine
3. Effects of oral administration of L-arginine on renal function in patients with heart failure
4. Preliminary report on the association of apolipoprotein E polymorphisms, with postoperative peak serum creatinine concentrations in cardiac surgical patients
5. Lack of renoprotective effects of dopamine and furosemide during cardiac surgery
6. Differences in pH management and pulsatile/nonpulsatile perfusion during cardiopulmonary bypass do not influence renal function
7. Effect of 'renal-dose' dopamine on renal function following cardiac surgery
8. Low-dose dopamine during cardiopulmonary bypass in patients with renal dysfunction
9. On-pump versus off-pump coronary revascularization: Evaluation of renal function
10. Off-pump versus on-pump coronary artery bypass surgery and postoperative renal dysfunction
11. Management of ischemic nephropathy: Dialysis-free survival after surgical repair
12. Intraoperative management of renal function in the surgical patient at risk. Focus on aortic surgery
13. The non-hemostatic liabilities of epsilon-aminocaproic acid: Hyperkalemia and renal impairment
14. Aprotinin and renal function in patients undergoing cardiac surgery
15. Operations on the thoracic aorta and hypothermic circulatory arrest: Is aprotinin safe?
16. The effect of aprotinin on renal function in orthotopic liver transplantation
17. The association of epsilon-aminocaproic acid with postoperative decrease in creatinine clearance in 1502 coronary bypass patients
18. Antifibrinolytic agents make 1- and 2-microglobulinuria poor markers of postcardiac surgery renal dysfunction
19. Effects of high-dose aprotinin on renal function in aortocoronary bypass grafting
20. Endotoxin, bile salts and renal function in obstructive jaundice
21. Prevention of postoperative renal dysfunction in patients with obstructive jaundice: A comparison of mannitol-induced diuresis and oral sodium taurocholate
22. Perioperative renal protection in patients with obstructive jaundice using drug combinations
23. Use of mannitol as a measure to prevent postoperative renal failure in patients with obstructive jaundice
24. Renal protection with the calcium antagonists
25. Dihydropyridine calcium antagonists and renal function in hypertensive kidney transplant recipients
26. The role of medullary ischemia in acute renal failure
27. Effects of celecoxib and naproxen on renal function in the elderly
28. Renal hemodynamics in radiocontrast medium-induced renal dysfunction: A role for dopamine-1 receptors
29. Prevention of radiocontrast-media-induced nephrotoxicity by the calcium channel blocker nitrendipine: A prospective randomised clinical trial
30. Prevention of radiographic contrast agent-induced reductions in renal function by acetylcysteine
31. Effects of low-flow sevoflurane anesthesia on renal function
32. Absence of biochemical evidence for renal and hepatic dysfunction after 8 hours of 1.25 minimum alveolar concentration sevoflurane anesthesia in volunteers
33. Nephrotoxicity of sevoflurane versus desflurane anesthesia in volunteers
34. Dose-related biochemical markers of renal injury after sevoflurane versus desflurane anesthesia in volunteers
35. Renal concentrating function with prolonged sevoflurane or enflurane anesthesia in volunteers
36. Assessment of low-flow sevoflurane and isoflurane effects on renal function using sensitive markers of tubular toxicity
37. The effects of sevoflurane and isoflurane anesthesia on renal tubular function in patients with moderately impaired renal function
38. The effects of sevoflurane on serum creatinine and blood urea nitrogen concentrations: A retrospective, twenty-two center, comparative evaluation of renal function in adult surgical patients
39. Long-term outcome of kidney transplants from non-headbeating donors: Multivariate analysis of factors affecting graft survival
40. Excellent long-term graft survival with kidneys from the uncontrolled non-heart-beating donor
41. Nondirected donation of kidneys from living donors
42. Outcome of coronary revascularization in patients on renal dialysis
43. Cardiac surgery in patients with end-stage renal disease: 10-year experience